论文部分内容阅读
一种具有广泛实际应用的新生物学技术将对商业起着较大的影响。杂交瘤(Hybrido-ma)技术大约是与 DNA 重组同一时间建立的,在后者的影响下发展起来的。然而,杂交瘤技术有可能使免疫学及其有关的研究和医学领域得到改革。
A kind of new biological technology with a wide range of practical applications will have a greater impact on the business. Hybrido-ma technology was established at about the same time as DNA recombination and developed under the influence of the latter. However, hybridoma technology is likely to revolutionize immunology and related research and medicine.